Insights

3 Soaring Warren Buffett Stocks You Can Buy for $76 or Less

When it comes to investing in good times and bad we could all learn a thing or two from Warren Buffett. He began running Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) way back in 1965 and the conglomerate has delivered an average annual return above 20% ever since.
The oracle of Omaha has made some unusual bets in recent years that are paying off well in 2022. Shares of Occidental Petroleum (NYSE: OXY), Kroger (NYSE: KR), and Bristol Myers Squibb (NYSE: BMY) have risen sharply in 2022, but it probably isn’t too late to buy some shares for your own portfolio. At recent prices, you can scoop up any of these stocks for $76 or less per share.

Berkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.

1. Occidental Petroleum
Buffett knows that abruptly removing millions of barrels of Russian oil from global supply lines will send prices skyrocketing. That’s why he’s been sinking billions into one of his favorite U.S. oil producers, Occidental Petroleum.
Back in 2019, Occidental Petroleum borrowed heavily to acquire Anadarko with assistance from Berkshire Hathaway. As a result, Occidental was still servicing a $29.4 billion debt load at the end of 2021. Being so heavily leveraged could lead to disaster if global oil prices collapse. It also means there’s a lot to gain if prices stay inflated as widely expected.
Shares of Occidental Petroleum have skyrocketed 117% since Russian forces began a full-scale invasion of Ukraine in February. Despite the big run-up, you can still scoop up shares for your own portfolio for around $57 at recent prices.
Before plowing all your cash into Occidental Petroleum or any oil stock, it’s important to remember that Russian president, Vladimir Putin, can unilaterally end the war and associated sanctions practically overnight if he so desires. That would be a disaster for Occidental’s stock price, but the global economic benefit would likely offset any losses if you keep this stock in a well-diversified portfolio.
2. Kroger
Buffett began acquiring shares of this supermarket chain in February of 2020 and he hasn’t looked back for good reasons. Kroger’s trounced the benchmark S&P 500 index with a gain of around 92% since Berkshire Hathaway told investors it acquired a large stake. Despite the run-up, you can still buy shares of Kroger for around $57 at the moment.
At recent prices, the stock offers a 1.5% dividend yield that’s rising fast. Kroger has been able to bump up its quarterly payout by 75% over the past five years and there is room for more raises ahead. The company has maintained its rising dividend commitment using just 16.5% of the free cash flow generated by operations over the past year. 
Kroger’s fresh first digital strategy appears to be working better than expected. Digital sales in the fourth quarter of 2021 were 105% higher than during the fourth quarter of 2019.
Kroger was also able to deliver an impressive $3.6 billion in free cash flow during 2021 even though it significantly raised employee wages. With one of the country’s largest grocery distribution networks running like a well-oiled machine, the company has a good chance to continue outperforming for many years to come.
3. Bristol Myers Squibb
The COVID pandemic reminded Buffett just how valuable drugs can be. In 2020, Berkshire Hathaway began raising its exposure to a handful of big pharmaceutical companies including Bristol Myers Squibb.
Shares of Bristol Myers Squibb have climbed around 21% this year even though the S&P 500 index has tumbled by more than 10% in 2021. Despite rising sharply, you can still buy this dividend-paying pharma stock for about $76 per share. At this price, the company’s dividend program offers a 2.9% yield.
Bristol Myers Squibb might not have any COVID-19 vaccine revenue to lean on. What it does have is three of last year’s 10 best-selling drugs. Its top product at the moment, Revlimid, produced $12.8 billion in revenue last year and it won’t lose patent-protected exclusivity for at least a few more years.
Cory Renauer has no position in any of the stocks mentioned. The Motley Fool owns and recommends Berkshire Hathaway (B shares) and Bristol Myers Squibb. The Motley Fool recommends the following options: long January 2023 $200 calls on Berkshire Hathaway (B shares), short January 2023 $200 puts on Berkshire Hathaway (B shares), and short January 2023 $265 calls on Berkshire Hathaway (B shares). The Motley Fool has a disclosure policy. –

When it comes to investing in good times and bad we could all learn a thing or two from Warren Buffett. He began running Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) way back in 1965 and the conglomerate has delivered an average annual return above 20% ever since.

The oracle of Omaha has made some unusual bets in recent years that are paying off well in 2022. Shares of Occidental Petroleum (NYSE: OXY), Kroger (NYSE: KR), and Bristol Myers Squibb (NYSE: BMY) have risen sharply in 2022, but it probably isn’t too late to buy some shares for your own portfolio. At recent prices, you can scoop up any of these stocks for $76 or less per share.

Berkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.

1. Occidental Petroleum

Buffett knows that abruptly removing millions of barrels of Russian oil from global supply lines will send prices skyrocketing. That’s why he’s been sinking billions into one of his favorite U.S. oil producers, Occidental Petroleum.

Back in 2019, Occidental Petroleum borrowed heavily to acquire Anadarko with assistance from Berkshire Hathaway. As a result, Occidental was still servicing a $29.4 billion debt load at the end of 2021. Being so heavily leveraged could lead to disaster if global oil prices collapse. It also means there’s a lot to gain if prices stay inflated as widely expected.

Shares of Occidental Petroleum have skyrocketed 117% since Russian forces began a full-scale invasion of Ukraine in February. Despite the big run-up, you can still scoop up shares for your own portfolio for around $57 at recent prices.

Before plowing all your cash into Occidental Petroleum or any oil stock, it’s important to remember that Russian president, Vladimir Putin, can unilaterally end the war and associated sanctions practically overnight if he so desires. That would be a disaster for Occidental’s stock price, but the global economic benefit would likely offset any losses if you keep this stock in a well-diversified portfolio.

2. Kroger

Buffett began acquiring shares of this supermarket chain in February of 2020 and he hasn’t looked back for good reasons. Kroger’s trounced the benchmark S&P 500 index with a gain of around 92% since Berkshire Hathaway told investors it acquired a large stake. Despite the run-up, you can still buy shares of Kroger for around $57 at the moment.

At recent prices, the stock offers a 1.5% dividend yield that’s rising fast. Kroger has been able to bump up its quarterly payout by 75% over the past five years and there is room for more raises ahead. The company has maintained its rising dividend commitment using just 16.5% of the free cash flow generated by operations over the past year. 

Kroger’s fresh first digital strategy appears to be working better than expected. Digital sales in the fourth quarter of 2021 were 105% higher than during the fourth quarter of 2019.

Kroger was also able to deliver an impressive $3.6 billion in free cash flow during 2021 even though it significantly raised employee wages. With one of the country’s largest grocery distribution networks running like a well-oiled machine, the company has a good chance to continue outperforming for many years to come.

3. Bristol Myers Squibb

The COVID pandemic reminded Buffett just how valuable drugs can be. In 2020, Berkshire Hathaway began raising its exposure to a handful of big pharmaceutical companies including Bristol Myers Squibb.

Shares of Bristol Myers Squibb have climbed around 21% this year even though the S&P 500 index has tumbled by more than 10% in 2021. Despite rising sharply, you can still buy this dividend-paying pharma stock for about $76 per share. At this price, the company’s dividend program offers a 2.9% yield.

Bristol Myers Squibb might not have any COVID-19 vaccine revenue to lean on. What it does have is three of last year’s 10 best-selling drugs. Its top product at the moment, Revlimid, produced $12.8 billion in revenue last year and it won’t lose patent-protected exclusivity for at least a few more years.

Cory Renauer has no position in any of the stocks mentioned. The Motley Fool owns and recommends Berkshire Hathaway (B shares) and Bristol Myers Squibb. The Motley Fool recommends the following options: long January 2023 $200 calls on Berkshire Hathaway (B shares), short January 2023 $200 puts on Berkshire Hathaway (B shares), and short January 2023 $265 calls on Berkshire Hathaway (B shares). The Motley Fool has a disclosure policy.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US & HK* Trades. Click Here!